Pathologisches Institut: Uniklinik Mannheim

What Pathologisches Institut: Uniklinik Mannheim does

The Pathologisches Institut is a public pathology department of Universitätsmedizin Mannheim, affiliated with the University of Heidelberg medical faculty, located at Theodor-Kutzer-Ufer 1-3 in Mannheim, Germany. It delivers a full-service diagnostic pathology portfolio covering histology, immunohistochemistry, molecular pathology, malignant tumor diagnostics, cytological diagnostics, nephropathology, intraoperative frozen section diagnostics, and autopsy services, serving both the internal clinical departments of UMM and external referring physicians and hospitals in the Rhine-Neckar region. Its core technology stack combines conventional histopathology with a digital pathology research infrastructure called the Tissue Image Center, molecular pathology workflows for biomarker identification, and biobanking capabilities that support both clinical diagnostics and translational research into tumor microenvironment, angiogenesis, and morphogenesis.

The institute operates as a research-oriented academic medical unit, with an interdisciplinary team under Professor Christoph Brochhausen-Delius conducting funded research in precision medicine, digital pathology, and single-cell analysis. It is a partner in the Fraunhofer Leistungszentrum Einzelzelltechnologien, cooperates internationally with the Chinese University of Hong Kong on mitochondrial dysfunction research, and maintains DAkkS accreditation as a medical testing laboratory (D-ML-13200-03-00) and as an inspection body (D-IS-13200-01-00). Revenue is generated through reimbursement under the German public healthcare system (GKV/PKV) for clinical diagnostic services, alongside competitive research funding from sources including the DFG and the European Union, and commissioned research collaborations. The institute also contributes to medical and natural sciences teaching at the University of Heidelberg.

Because it is a department of a public university hospital rather than an independent commercial entity, the institute is government-owned, not publicly traded, and not subject to traditional PE/VC/M&A transactions; its strategic positioning is anchored in academic standing, regulated quality credentials, and integration into the UMM clinical pathway rather than commercial market share.

Name

Pathologisches Institut: Uniklinik Mannheim

Legal name

Pathologisches Institut – Universitätsmedizin Mannheim

Website

https://pathologie-uniklinikum-mannheim.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Pathologisches Institut is the public pathology department of Universitätsmedizin Mannheim (University of Heidelberg), providing clinical diagnostic pathology, biobanking, and digital pathology research to UMM's clinical departments and external regional referring physicians in Germany.

Ownership category

akta.pro rank

Product category

Clinical Pathology Diagnostics

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Clinical pathology services
• Histopathological diagnostics
• Molecular pathology testing
• Digital pathology research
• Cancer diagnostics

Headquarters

HQ city

Mannheim

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Clinical Diagnostic Services: As a department of the public university hospital Universitätsmedizin Mannheim, the institute generates revenue through the German public healthcare system (GKV/PKV) reimbursement for diagnostic pathology services performed for patients and referring physicians.
2. Research Funding: National and international research collaborations and commissioned research (Auftragsforschung) funded by grants from Deutsche Forschungsgemeinschaft (DFG), European Union, and other research funding bodies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Pathologisches Institut – Universitätsmedizin Mannheim is a university hospital pathology department providing clinical diagnostic services — including histology, immunohistochemistry, molecular pathology, malignant tumor diagnostics, cytology, nephropathology, frozen section diagnostics, and autopsy services — combined with academic research in digital pathology, precision medicine, and biobanking, and teaching for medical and natural sciences students at the University of Heidelberg. It serves as a diagnostic and consultative partner to clinical departments at UMM and to external referring physicians and hospitals in the Rhine-Neckar region.

Product overview

The Pathologisches Institut offers comprehensive diagnostic pathology services as a unified portfolio of eight core clinical services, complemented by a dedicated research infrastructure. The diagnostic services include Histology, Immunohistochemistry, Molecular Pathology, Malignant Tumor Diagnostics, Cytological Diagnostics, Nephropathology, Frozen Section Diagnostics, and Autopsy Services. These services work in an integrated manner to provide precise diagnoses essential for cancer treatment decisions, including tumor type determination, staging, intraoperative guidance, and molecular classification for tumor boards. The Tissue Image Center supports the diagnostic portfolio with digital pathology research capabilities for tissue imaging and single-cell analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Tissue Image Center: Digital pathology imaging center for tissue analysis and research

Products and services

• Histologie (Histology)

Quantifiable outcome

• Critical enabler of cancer treatment decisions: diagnosis of cancer type, tumor staging, intraoperative rapid sections, and molecular classification in tumor boards

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Fraunhofer Leistungszentrum EinzelzelltechnologiencoreStrategic or Co-development PartnerFormal partner institution in the Fraunhofer Performance Center for Single Cell Technologies. Provides research infrastructure and expertise in single-cell analysis, contributing to research on cellular mechanisms in oncology and chronic diseases.
• Chinese University of Hong KongcoreStrategic or Co-development PartnerInternational research cooperation focused on mitochondrial dysfunction and its pathophysiological significance for osteoporosis and sarcopenia. Represents cross-institutional research collaboration in disease mechanisms.
• University of Heidelberg (Universität Heidelberg)coreStrategic or Co-development PartnerAcademic parent institution. The Pathological Institute is part of the University of Heidelberg medical faculty, enabling integration with broader research networks, medical education programs, and academic collaboration.
• GBN (German Bioimaging Neuro) CommunityminorStrategic or Co-development PartnerCollaboration in the GBN-Community-Meeting to be held in Mannheim 2026. Research network focused on bioimaging and neural pathology research.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/pathologisches-institut-uniklinik-mannheim

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pathologisches Institut: Uniklinik Mannheim